Диссертация (1140116), страница 34
Текст из файла (страница 34)
31, N 6. – P. 910–916.14563. Bourassa, E.A. Angiotensin modulation of rostral ventrolateral medulla (RVLM) incardiovascular regulation / E.A. Bourassa, A.F. Sved, R.C. Speth // Molecular and CellularEndocrinology. – 2009. – Vol. 302, N 2. – P. 167–175.64. Katusic, Z.S. Endothelial nitric oxide: protector of a healthy mind / Z.S.
Katusic, S.A. Austin //European Heart Journal. – 2014. – Vol. 35. – P. 888–894.65. Cipolla MJ. The Cerebral Circulation. San Rafael, CA: Morgan & Claypool Life Sciences;2009:1–59.66. Faraci, F.M. Protecting against vascular disease in brain / F.M. Faraci // American JournalPhysiology-Heart and Circulatory Physiology. – 2011. – Vol. 300. – P. H1566–H1582.67. Vascular dysfunction in the pathogenesis of Alzheimer’s disease: a review of endotheliummediated mechanisms and ensuing vicious circles / L.Y.
Di Marco, A. Venneri, E. Farkas [etal.] // Neurobiology of Disease. – 2015. – Vol. 82. – P. 593–606.68. Madden, J.A. Role of the vascular endothelium and plaque in acute ischemic stroke /Neurology. – 2012. – Vol. 79 (suppl. 1). – P. S58–S62.69. Endothelial function and white matter hyperintensities in older adults with cardiovasculardisease / K.F.
Hoth, D.F. Tate, A. Poppas [et al.] // Stroke. – 2007. – Vol. 38. – P. 308–312.70. Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: areview / A. Poggesi, M. Pasi, F. Pescini [et al.] // Journal of Cerebral Blood Flow &Metabolism. – 2016. – Vol. 36. – P. 72–94.71. Iadecola, C. The pathobiology of vascular dementia / C.
Iadecola // Neuron. – 2013. – Vol. 80.– P. 844– 866.72. Gualtieri, C.T. The frequency of cognitive impairment in patients with anxiety, depression andbipolar disorder: an uncounted source of variance in clinical trials / C.T. Gualtieri, D. Morgan// Journal of Clinical Psychiatry. - 2008. – Vol. 69, N 7. – P. 1122-1130.73. Association of Anxiety and Depression with Hypertension Control: A U.S.
Multi-DisciplinaryGroup Practice Observational Study / A.K. Hо, C.T. Thorpe, N. Pandhi [et al.] // Journal ofHypertension. – 2015. – Vol. 33, N 11. – P. 2215–2222.74. Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists /J.M. Saavedra, H.
Ando, I. Armando [et al.] // Regulatory Peptides. – 2005. – Vol. 128, N 3. –P. 227–238.75. Anxiety, depression and autonomic nervous system dysfunction in hypertension / Z. Bajko,C.C. Szekeres, K.R. Kovacs [et al.] // Journal Neurological Sciences.
– 2012. – Vol. 317, N(1–2). – P. 112–116.14676. Kudielka, B.M. Human models in acute and chronic stress: assessing determinants ofindividual hypothalamus-pituitary-adrenal axis activity and reactivity / B.M. Kudielka, S. Wüst// Stress. – 2009. – Vol. 13, N 1. – P. 1–14.77. Anxiety and depression are associated with unhealthy lifestyle in patients at risk ofcardiovascular disease / F.
Bonnet, K. Irving, J.L. Terra [et al.] // Atherosclerosis. – 2005. –Vol. 178, N 2. – P. 339–344.78. Anxiety disorders in older adults: A comprehensive review / K.B. Wolitzky-Taylor, N.Castriotta, E.J. Lenze [et al.] // Depression and Anxiety. – 2010. – Vol. 27. – P. 190–211.79. Player, M.S. Anxiety disorders, hypertension, and cardiovascular risk: a review / M.S. Player,L.E. Peterson // The International Journal of Psychiatry in Medicine. – 2011. – Vol. 41. – P.365–377.80.
Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stablecoronary heart disease: The Heart and Soul Study / E.J. Martens, P. de Jonge, B. Na [et al.] //Archives of general psychiatry. – 2010. – Vol. 67. – P. 750–758.81. The synergistic effects of anxiety and cerebral hypoperfusion on cognitive dysfunction in olderadults with cardiovascular disease / M.L.
Alosco, J. Gunstad, C. Beard [et al.] // Journal ofGeriatric Psychiatry and Neurology. – 2015. – Vol. 28, N 1. – P. 57–66.82. Emotion regulation and the anxiety disorders: An integrative review / J.M. Cisler, B.O.Olatunji, M.T. Feldner [et al.] // Journal of Psychopathology and Behavioral Assessment. –2010. – Vol. 32. – P. 68–82.83. Failure of anterior cingulate activation and connectivity with the amygdala during implicitregulation of emotional processing in generalized anxiety disorder / A. Etkin, K.E. Prater, F.Hoeft [et al.] // American Journal of Psychiatry.
– 2010. – Vol. 167., P. 545–554.84. Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly.EVA Study Group / C. Tzourio, C. Dufouil, P. Ducimetière [et al.] // Neurology. - 1999. –Vol. 53, N 9. – P. 1948–1952.85. Cross-sectional and longitudinal association between antihypertensive medications andcognitive impairment in an elderly population / I. Hajjar, H. Catoe, S.
Sixta [et al.] // Thejournals of gerontology. Series A, Biological sciences and medical sciences. – 2005. – Vol. 60,N 1. – P. 67–73.86. Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study /E.S.C. Korf, L.R. White, P. Scheltens [et al.] // Hypertension. – 2004.
– Vol. 44, N 1. – P. 29–34.87. Revising the definition of Alzheimer’s disease: a new lexicon / B. Dubois, H.H. Feldman, C.Jacova [et al.] // Lancet Neurologyogy. – 2010. – Vol. 9, N 11. – P. 1118– 1127.14788. Temporal evolution of cognitive changes in incident hypertension prospective cohort studyacross the adult age span / S. Köhler, M.A.E.
Baars, P. Spauwen [et al.] // Hypertension. –2014. – Vol. 63. – P. 245-251.89. Medical research council trial of treatment of hypertension in older adults: principal results.MRC Working Party. Bmj. 1992;304 (6824):405–41290. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of arandomized double-blind intervention trial / H. Lithell, L. Hansson, I. Skoog [et al.] // Journalof Hypertension. – 2003. – Vol. 21, N 5. – P. 875–886.91. Effects of aspirin plus extended release dipyridamole versus clopidogrel and telmisartan ondisability and cognitive function after recurrent stroke in patients with ischaemic stroke in thePrevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind,active and placebo-controlled study / H-C. Diener, R.L. Sacco, S.
Yusuf [et al.] // LancetNeurology. – 2008. – Vol. 7, N 10. – P. 875–884.92. Renin-angiotensin system blockade and cognitive function in patients at high risk ofcardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies / C.Anderson, K. Teo, P. Gao [et al.] // Lancet Neurology. – 2011. – Vol. 10, N 1.
– P. 43–53.93. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events inhigh-risk patients. The heart outcomes prevention evaluation study investigators / S. Yusuf, P.Sleight, J. Pogue [et al.] // New England Journal of Medicine. – 2000. – Vol. 342, N 3. – P.145–153.94. Use of ramipril in preventing stroke: double blind randomised trial / J. Bosch, S.
Yusuf, J.Pogue [et al.] // Bmj. – 2002. – Vol. 324, N 7339. – P. 699–702.95. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia andcognitive decline in patients with cerebrovascular disease / C. Tzourio, C. Anderson, N.Chapman [et al.] // Archives of Internal Medicine. – 2003. – Vol. 163, N 9. – P. 1069–1075.96. Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review ofobservational studies, randomized controlled trials and meta-analyses, with discussion ofpotential mechanisms / L. Rouch, P. Cestac, O.
Hanon [et al.] // CNS Drugs. – 2015. – Vol. 29,N 2. – P. 113–130.97. Relationship Between Antihypertensive Medications and Cognitive Impairment: Part I. Reviewof Human Studies and Clinical Trials / S. Yasar, M. Schuchman, J. Peters [et al.] // CurrentHypertension Reports. – 2016. – Vol.
18, N 8. – P. 6798. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers anddihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-148inhibitors / A. Fournier, R. Oprisiu-Fournier, J.M. Serot [et al.] // Expert Review ofNeurotherapeutics. - 2009. – Vol. 9, N 9. – P.
1413–1431.99. Does use of antihypertensive drugs affect the incidence or progression of dementia? Asystematic review /K. Shah, S. Qureshi, M. Johnson [et al.] // The American Journal ofGeriatric Pharmacotherapy. - 2009. – Vol. 7, N 5. – P. 250–261.100. Treatment options and considerations for hypertensive patients to prevent dementia / I.Hernandorena, E. Duron, J-S. Vidal [et al.] // Expert Opinion on Pharmacotherapy. - 2017. –Vol. 18, N 10. – P. 989-1000.101. Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination onambulatory blood pressure and cognitive function in elderly hypertensive patients / R.
Fogari, A.Mugellini, A. Zoppi [et al.] // Journal of Human Hypertension. – 2006. – Vol. 20. – P. 177–185.102. Гарелик, И.А. Влияние фиксированных комбинаций валсартан/гидрохлортиазид иквинаприл/ гидрохлортиазид на когнитивные функции / И.А. Гарелик // Здоровье иобразование в XXI веке. - 2016. – Т. 18, № 12. – С. 23-24.103.
Elfimova, E. Effect of antihypertensive therapy on psychological and cognitive status inpatients with arterial hypertension, obesity and obstructive sleep apnoea / E. Elfimova, A. Litvin// Journal of Hypertension. – 2018. – Vol. 36 (e-Suppl. 1). – P. e278.104. Влияние комбинированной антигипертензивной терапии индапамидом и периндоприломна морфофункциональные параметры сердца, сосудов мелкого и среднего калибра икогнитивную функцию у пациентов с гипертонической болезнью / Е.А.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
